PubMed

Improvement of glycemic control by 1 year of insulin therapy leads to a sustained decrease in sE-selectin concentrations in type 2 diabetes.

Ryysy L, Yki-Järvinen H.

Diabetes Care. 2001 Mar;24(3):549-54.PMID: 11289483 [PubMed - indexed for MEDLINE]Related articlesFree article

Correction of hyperglycaemia reduces insulin resistance and serum soluble E-selectin levels in patients with Type 2 diabetes mellitus.

Matsumoto K, Nakamura H, Ueki Y, Tominaga T, Miyake S.

Diabet Med. 2001 Mar;18(3):224-8.PMID: 11318844 [PubMed - indexed for MEDLINE]Related articles

Elevated concentrations of soluble E-selectin and vascular cell adhesion molecule-1 in NIDDM. Effect of intensive insulin treatment.

Albertini JP, Valensi P, Lormeau B, Aurousseau MH, Ferrière F, Attali JR, Gattegno L.

Diabetes Care. 1998 Jun;21(6):1008-13.PMID: 9614623 [PubMed - indexed for MEDLINE]Related articlesFree article

E-selectin plasma concentration is influenced by glycaemic control in NIDDM patients: possible role of oxidative stress.

Cominacini L, Fratta Pasini A, Garbin U, Campagnola M, Davoli A, Rigoni A, Zenti MG, Pastorino AM, Lo Cascio V.

Diabetologia. 1997 May;40(5):584-9.PMID: 9165228 [PubMed - indexed for MEDLINE]Related articles

Circulating E-selectin, vascular cell adhesion molecule-1, and intercellular adhesion molecule-1 in men with coronary artery disease assessed by angiography and disturbances of carbohydrate metabolism.

Kowalska I, Straczkowski M, Szelachowska M, Kinalska I, Prokop J, Bachórzewska-Gajewska H, Stepien A.

Metabolism. 2002 Jun;51(6):733-6.PMID: 12037726 [PubMed - indexed for MEDLINE]Related articles

Effect of metformin treatment on multiple cardiovascular disease risk factors in patients with type 2 diabetes mellitus.

Abbasi F, Chu JW, McLaughlin T, Lamendola C, Leary ET, Reaven GM.

Metabolism. 2004 Feb;53(2):159-64.PMID: 14767866 [PubMed - indexed for MEDLINE]Related articles

Veterans Affairs Cooperative Study on glycemic control and complications in type II diabetes (VA CSDM). Results of the feasibility trial. Veterans Affairs Cooperative Study in Type II Diabetes.

Abraira C, Colwell JA, Nuttall FQ, Sawin CT, Nagel NJ, Comstock JP, Emanuele NV, Levin SR, Henderson W, Lee HS.

Diabetes Care. 1995 Aug;18(8):1113-23.PMID: 7587846 [PubMed - indexed for MEDLINE]Related articles

The effects of metformin on glycemic control and serum lipids in insulin-treated NIDDM patients with suboptimal metabolic control.

Robinson AC, Burke J, Robinson S, Johnston DG, Elkeles RS.

Diabetes Care. 1998 May;21(5):701-5.PMID: 9589227 [PubMed - indexed for MEDLINE]Related articlesFree article

Effects of short-term treatment with metformin on markers of endothelial function and inflammatory activity in type 2 diabetes mellitus: a randomized, placebo-controlled trial.

De Jager J, Kooy A, Lehert P, Bets D, Wulffelé MG, Teerlink T, Scheffer PG, Schalkwijk CG, Donker AJ, Stehouwer CD.

J Intern Med. 2005 Jan;257(1):100-9.PMID: 15606381 [PubMed - indexed for MEDLINE]Related articles

Serum concentrations of soluble adhesion molecules are related to degree of hyperglycemia and insulin resistance in patients with type 2 diabetes mellitus.

Matsumoto K, Sera Y, Nakamura H, Ueki Y, Miyake S.

Diabetes Res Clin Pract. 2002 Feb;55(2):131-8.PMID: 11796179 [PubMed - indexed for MEDLINE]Related articles

Safety and efficacy of normalizing fasting glucose with bedtime NPH insulin alone in NIDDM.

Cusi K, Cunningham GR, Comstock JP.

Diabetes Care. 1995 Jun;18(6):843-51.PMID: 7555511 [PubMed - indexed for MEDLINE]Related articles

Improved glycemic control increases fasting plasma acylation-stimulating protein and decreases leptin concentrations in type II diabetic subjects.

Ozata M, Gungor D, Turan M, Ozisik G, Bingol N, Ozgurtas T, Ozdemir IC.

J Clin Endocrinol Metab. 2001 Aug;86(8):3659-64.PMID: 11502793 [PubMed - indexed for MEDLINE]Related articlesFree article

Effect of repaglinide addition to metformin monotherapy on glycemic control in patients with type 2 diabetes.

Moses R, Slobodniuk R, Boyages S, Colagiuri S, Kidson W, Carter J, Donnelly T, Moffitt P, Hopkins H.

Diabetes Care. 1999 Jan;22(1):119-24.PMID: 10333912 [PubMed - indexed for MEDLINE]Related articlesFree article

Comparison of bedtime NPH or preprandial regular insulin combined with glibenclamide in secondary sulfonylurea failure.

Landstedt-Hallin L, Adamson U, Arner P, Bolinder J, Lins PE.

Diabetes Care. 1995 Aug;18(8):1183-6.PMID: 7587856 [PubMed - indexed for MEDLINE]Related articles

Concentrations of circulating P-selectin are increased in patients with newly diagnosed insulin-dependent diabetes mellitus.

Kopp HP, Hopmeier P, Schernthaner G.

Exp Clin Endocrinol Diabetes. 1998;106(1):41-4.PMID: 9516058 [PubMed - indexed for MEDLINE]Related articles

The levels of soluble adhesion molecules in diabetic and nondiabetic patients with combined hyperlipoproteinemia and the effect of ciprofibrate therapy.

Okapcova J, Gabor D.

Angiology. 2004 Nov-Dec;55(6):629-39.PMID: 15547649 [PubMed - indexed for MEDLINE]Related articles

Soluble vascular cell adhesion molecule-1 and E-selectin levels in relation to vascular risk factors and to E-selectin genotype in the first degree relatives of NIDDM patients and in NIDDM patients.

Bannan S, Mansfield MW, Grant PJ.

Diabetologia. 1998 Apr;41(4):460-6.PMID: 9562351 [PubMed - indexed for MEDLINE]Related articles

High serum concentrations of soluble E-selectin correlate with obesity but not fat distribution in patients with type 2 diabetes mellitus.

Matsumoto K, Sera Y, Abe Y, Tominaga T, Horikami K, Hirao K, Ueki Y, Miyake S.

Metabolism. 2002 Jul;51(7):932-4.PMID: 12077744 [PubMed - indexed for MEDLINE]Related articles

Relation between glycaemic control, hyperinsulinaemia and plasma concentrations of soluble adhesion molecules in patients with impaired glucose tolerance or Type II diabetes.

Blüher M, Unger R, Rassoul F, Richter V, Paschke R.

Diabetologia. 2002 Feb;45(2):210-6.PMID: 11935152 [PubMed - indexed for MEDLINE]Related articles

Relation between soluble adhesion molecules and insulin sensitivity in type 2 diabetic individuals: role of adipose tissue.

Targher G, Bonadonna RC, Alberiche M, Zenere MB, Muggeo M, Bonora E.

Diabetes Care. 2001 Nov;24(11):1961-6.PMID: 11679465 [PubMed - indexed for MEDLINE]Related articlesFree article